ALB and neoplasm: In addition, increased age (HR 1.057, P < 0.001), higher MELD score (HR 1.078, P = 0.027), bigger tumor size (HR 1.083, P = 0.004), lower serum albumin level (HR 0.523, P < 0.001), lower platelet level (HR 0.996, P = 0.006), more advanced BCLC stage (stage A, HR 1.711; stage B, HR 2.003; P = 0.015), not obtaining objective response (HR 0.680, P = 0.023) were significant prognostic factors for short life expectancy (Table 3).